Background illustration for clinical trials search

Bristol Myers Squibb Clinical Trials

Find clinical trials for Bristol Myers Squibb. Search for Bristol Myers Squibb clinical trials in different cities and states across the United States.

Filter

A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administration in Healthy Adult Participants

for
Healthy Volunteers
Location: Lenexa KS
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Sex: All

Age: 18 - 65

Code: NCT07204418

Phase 1, Recruiting

Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)

for
Schizophrenia
Location: Boston MA, New York NY, Belle Mead NJ, Baltimore MD,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07101094

Recruiting

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

for
Schizophrenia
Location: Marlton NJ, Hollywood FL, Miami Lakes FL, Decatur GA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18 - 55

Code: NCT07061288

Phase 1, Recruiting

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

for
Plaque Psoriasis
Location: St. John's, Portsmouth NH, Brighton MA, Milford MA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 40+

Code: NCT07116967

Phase 3, Recruiting

A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring

for
Ulcerative Colitis
Location: Wilmington NC
Sponsor: Bristol-Myers Squibb

Sex: Female

Age: 0+

Code: NCT05953402

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

for
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Location: Boston MA, Hawthorne NY, Richmond VA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07063745

Phase 2, Phase 3, Recruiting

A Phase 1 Study of Navlimetostat Tablet Formulations

for
Healthy Participants
Location: Decatur GA
Sponsor: Bristol-Myers Squibb

Sex: Female

Age: 18 - 55

Code: NCT07544628

Phase 1, Recruiting

A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)

for
Alzheimer Disease, Psychosis
Location: Independence OH, Gilbert AZ, Chino CA
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 55 - 70+

Code: NCT06947941

Phase 3, Recruiting

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

for
Plaque Psoriasis
Location: St. John's, Milford MA, Philadelphia PA, Rockville MD,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 12 - 17

Code: NCT06979453

Phase 3, Recruiting

A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132

for
Systemic Lupus Erythematosus (SLE),
Location: New York NY, Oklahoma City OK
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18 - 70+

Code: NCT06875960

Recruiting

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

for
Breast Neoplasms
Location: Boston MA, Sherbrooke, Westbury NY, White Plains NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06926868

Phase 2, Phase 3, Recruiting

A Study to Assess Deucravacitinib Safety in Pregnancy

for
Psoriasis (PsO)
Location: La Jolla CA
Sponsor: Bristol-Myers Squibb

Sex: Female

Age: 0+

Code: NCT07017699

Recruiting

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

for
Bipolar Disorder Type I With Mania or Mania With Mixed Features
Location: Marlton NJ, Gaithersburg MD, West Palm Beach FL,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18 - 65

Code: NCT06951711

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

for
Alzheimer's Disease
Location: West Long Branch NJ, Albany NY, Springfield NJ,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 60 - 70+

Code: NCT06976203

Phase 3, Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

for
Alzheimer's Disease
Location: Valley Stream NY, Staten Island NY, Morehead City NC,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 55 - 70+

Code: NCT07011745

Phase 3, Recruiting

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

for
Advanced Solid Tumor, Advanced Breast Cancer,
Location: Lebanon NH, New Hyde Park NY, New York NY, Buffalo NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06997029

Phase 1, Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

for
Alzheimer Disease
Location: South Dartmouth MA, Newton MA, Springfield MA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 55 - 70+

Code: NCT07011732

Phase 3, Recruiting

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

for
Mesothelioma, Non Small Cell Lung Cancer,
Location: Brookline MA, Port Jefferson Station NY, Mineola NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT05245500

Phase 1, Recruiting

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

for
Obstructive Hypertrophic Cardiomyopathy
Location: Boston MA, Roslyn NY, Valhalla NY, New York NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT05489705

Recruiting

A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)

for
Carcinoma, Non-Small-Cell Lung
Location: Boston MA, New York NY, Canton OH, Detroit MI,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06855771

Phase 2, Recruiting